Document is current
Any future updates will be listed below
-
Authors
Foreman, Yuri D. http://orcid.org/0000-0002-0035-1586
Brouwers, Martijn C. G. J.
Berendschot, Tos T. J. M.
van Dongen, Martien C. J. M.
Eussen, Simone J. P. M.
van Greevenbroek, Marleen M. J.
Henry, Ronald M. A.
Houben, Alfons J. H. M.
van der Kallen, Carla J. H.
Kroon, Abraham A.
Reesink, Koen D.
Schram, Miranda T.
Schaper, Nicolaas C.
Stehouwer, Coen D. A.
-
Funding
Funding for this research was provided by:
European Regional Development Fund
Province of limburg
Ministerie van Economische Zaken (31O.041)
Stichting De Weijerhorst
Pearl String Initiative Diabetes
CARIM School for Cardiovascular Diseases, Universiteit Maastricht
Care and Public Health Research Institute
NUTRIM School for Nutrition and Translational Research in Metabolism
Stichting Sint Annadal
Health Foundation Limburg
Janssen-Cilag B.V.
Novo Nordisk Farma B.V.
Sanofi-Aventis Netherlands B.V.
Medtronic
- License Information
-
More Information
Article History
Received: 21 August 2019
Accepted: 23 October 2019
First Online: 14 November 2019
Ethics approval and consent to participate
: The Maastricht Study has been approved by the institutional medical ethical committee (NL31329.068.10) and the Minister of Health, Welfare and Sports of the Netherlands (Permit 131088-105234-PG). All participants gave written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
